On November 28, 2023, Vietnam Evaluation Report Joint Stock Company (Vietnam Report) officially announced the Top 10 prestigious Pharmaceutical Companies in 2023. Top 10 reputable Pharmaceutical Companies are built on scientific and objective principles. Companies are evaluated and ranked based on 3 main criteria: (1) Financial capacity shown on the most recent year’s financial statements;
Vietnam is focusing on improving research capacity and application of new drug production technology, promoting clinical pharmacy development and strengthening supervision of safe and reasonable drug use. Vietnam is focusing on improving research capacity and application of new drug production technology, promoting clinical pharmacy development and strengthening supervision of safe and reasonable drug use, aiming
It is critical for pharmaceutical companies to improve competitiveness with a focus on research and development (R&D), production technology and digitalisation. According to experts, this will help them expand their shares in the domestic market which remains being dominated by imported drugs and extend their international reach.Vietnam’s pharmaceutical market has significant potential. The Ministry of
Despite having a good market, the pharmaceutical manufacturing in Vietnam still faces many difficulties. This difficulty comes from industry competition, world competition and technological development. In order for the pharmaceutical manufacturing to develop, what should pharmaceutical enterprises do? Overview of Vietnam’s pharmaceutical manufacturing industry 2023.The market for the pharmaceutical industry in Vietnam is relatively active:The
On November 28, 2023, Vietnam Evaluation Report Joint Stock Company (Vietnam Report) officially announced the Top 10 prestigious Pharmaceutical Companies in 2023. Top 10 reputable Pharmaceutical Companies are built on scientific and objective principles. Companies are evaluated and ranked based on 3 main criteria: (1) Financial capacity shown on the most recent year’s financial statements;
By Mr. Ong Van Dung, General Director, Stellapharm Stellapharm (former name was STADA-VN – a Joint Venture Pharmaceutical Company formed in 2002 with a Vietnamesecompany named M.S.T and German cooperation named STADA Arzneimittel). Stellapharm has become one of the leading generic pharmaceutical manufacturers in Vietnam, we follow the global quality standard in accordance with European
As one of seven generic drug manufacturers selected by MPP and becoming a sub-licensee of Shionogi – a Japanese pharmaceutical manufacturer to produce of XOCOVA™ drug, generic version. Stellapharm is honored and proud to have contributed to repelling the COVID-19 pandemic with drugs. This is the third oral product in the world to be recognized
Sept 29 (Reuters) – Laboratory studies show that Merck & Co’s (MRK.N) experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmissible Delta, the company said on Wednesday. Since molnupiravir does not target the spike protein of the virus – the target of
Since the beginning of February this year, many consignments of Stella’s pharmaceutical products with a total of nearly 200 million units have been urgently exported by air to markets in Germany, France, Austria, Belgium, Ireland, etc.
This will be the first steroid-hormone pharmaceutical factory in Vietnam and among a few ASEAN factories built in compliance with European Standards for this line of products.
STADA – VN JOINT VENTURE CO., LTD. officially changed its name to STELLAPHARM J.V. CO., LTD. since 16 August 2019.
“Accrediting the fifth EU-GMP is one of our commitment on maintaining highest EU standards and quality of products with affordable prices” said by Choo Yan Ho, the Chairman.
Lesovir is manufactured by its EU-GMP facility and distributed via exclusive distributor, Khuong Duy Pharma Co., Ltd.
On 15 March 2016, the fourth EU-GMP Inspection was conducted at STADA – VN J.V. Co., Ltd., Binh Duong Branch, currently known as STELLAPHARM J.V. Co., Ltd. – Branch 1
On 06 January 2015, STADA – VN J.V. Co., Ltd., Binh Duong Branch (the “STELLA” or “Factory II“), was appreciated by Ministry of Health, Labour and Welfare (the “MHLW”) issued the certificate of Japan GMP for the product of Soleton 80 with its composition and strength: Zaltoprofen 80 mg
On 19 March 2013, the third EU-GMP Inspection was conducted in five continuous days at STADA – VN J.V. Co., Ltd., Binh Duong Branch (the “Company” or “Factory II“), located at Vietnam – Singapore Industrial Park, Binh Duong and the Factory II was recognized as a pharma facility complying with European Good Manufacturing Practice issued
In the meeting, besides the feedback on how to choose a safe diet pill without any active elements which may cause harmful effect to health, Consultants of STADA-VN JOINT VENTURE CO., LTD also held discussion to explain the efficiency of the productsas well as consulted various diet assistance methods which can bring the best effect.
From August 15 – 19, 2011, the delegates from WHO International have inspected STADA plant at VSIP.
STADA-VN has been acknowledged as one of the most prestigious enterprises on the domestic pharmaceutical market. Recently, STADA-VN has held a “Customer Conference” in Binh Duong province on 18 June 2011.
On 06 May 2011, STADA-VN has participated in the Conference and Exhibition on Drug held by Ho Chi Minh City Health Department together with more than 40 pharmaceutical manufacturers.
On 24/04/2011, STADA-VN as a sponsor has coordinated with Hospital 115 held the medical examination and treatment activities for the poor in Tra Vinh Province. There are over 500 people received medicines from the activities.
With the mission “Towards the community health”, STADA-VN has attended to the parade of Food Safety, Hygiene and Quality held on April 09, 2011 in Binh Duong Province.
To help customers learn more about methods for losing weight safely and effectively, STADA-Vietnam Joint Venture Co., Ltd. and Thanh Nien Online held together a successful online consulting of “Nutrition and Weight Loss” on April 07,
On March 12, 2011, STADA-VN organized the seminar, “Update on the progress for the treatment of Hypertension and Coronary Artery Disease” lectured by Assoc. Prof. Pham Nguyen Vinh – Vice Chairman of Vietnam Cardiovascular Association, Director of Tam Duc Heart Hospital.
Following the advertising campaign of April 2010 for the Orlistat STADA Diet Pill, on 08 January 2011, STADA – VN JOINT VENTURE CO., LTD cooperated with our exclusive distributor – Khuong Duy Pharmaceutical Co., Ltd to organize a meeting for our customers in Ho Chi Minh City.
In cooperation with our exclusive distributor – Khuong Duy Pharmaceutical Co., Ltd, on 28 February 2011, STADA – VN JOINT VENTURE CO., LTD held a New Year Meeting for all KD’s Chief of Representative Office and provincial agents.
In the happy and rejoiced atmosphere of the first days of the year, on 22 January 2011, STADA – VN JOINT VENTURE CO., LTD organized the 2010 year-end party with the topic “STADA – Continuous Development”. The party was hosted at Factory No. II
As a co-sponsor, on 22 January 2011, STADA – VN JOINT VENTURE CO., LTD was pleased to join the Year-end party of HCMC Pharmaceutical Association held at the Faculty of Pharmacy of HCMC.
In the second quarter of 2010, STADA-VN held a series of Cardiovascular Seminars for hospital doctors working outside Ho Chi Minh City.
STADA-VN has been acknowledged as one of the most prestigious enterprises in the domestic pharmaceutical market. Recently, STADA-VN has held several “Customer Conferences” in provinces throughout Vietnam.
QC Training workshop: A training workshop by Dr. Carmen González Espínola – Senior Manager Quality Assurance from STADA Arzneimittel AG was conducted at STADA-VN, VSIP factory from 15 to 19 March 2010.
Recently, the storm No. 11 landed in the central provinces of Vietnam caused severe devastation, materially as well as mentally, to the residents therein.
